-
NurOwn Cell Therapy Advances To Phase 3 Trial, Fully Enrolled With 200 Patients
ALS News Today’s forums moderator, Amanda Sifford, discusses how the NurOwn Cell Therapy advances to a Phase 3 Trial which is fully enrolled with 200 patients.
Are you interested in learning more about ALS? If so, please visit alsnewstoday.com/
What do you think about this news? Listen to this flash briefing episode and share your thoughts in the comment section below!
Sorry, there were no replies found.
Log in to reply.